MedPath

Local Anesthesia in Radial Catheterization

Phase 4
Conditions
Anesthesia, Local
Catheter Site Discomfort
Coronary Artery Disease
Catheter Site Pain
Interventions
Drug: Local anesthetic
Drug: local anaesthetic injection
Registration Number
NCT03072394
Lead Sponsor
Hippocration General Hospital
Brief Summary

A randomized clinical trial to test the efficacy of EMLA cream (lidocaine 2.5% and prilocaine 2.5% in a ratio of 1:1 by weight) in comparison to the established local anesthesia (LA) protocol of lidocaine subcutaneous injection, in providing adequate peri-operative local anesthesia during transradial coronary angiography.

Detailed Description

A total of 444 consecutive patients, who are referred for elective coronary angiography to 1st Cardiology Department cathlab, with the suspicion of coronary artery disease (CAD) will be enrolled in this study. Exclusion criteria are acute coronary syndrome, previous ipsilateral transradial approach, Raynaud's syndrome, abnormal renal function with or without need for hemodialysis, known history of sensitivity to local anesthetics, non-palpable radial pulse, abnormal Barbeau's test and patient's refusal. Baseline clinical, demographic and procedural data of the study population were recorded.

Participants will be randomly assigned to either the EMLA (AO) or the lidocaine group (LA), by a randomization table.

Primary end-point: the perception of radial pain assessed during artery puncture and 30 minutes after sheath removal.

Secondary end-point: The number of puncture attempts, the total time required before successful sheath insertion, and the occurrence of radial artery spasm will be also documented in each group

Participants will be observed for 4 hours post angiography for development of local complications or side effects.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
444
Inclusion Criteria
  • referral for elective diagnostic coronary angiography
Exclusion Criteria
  • acute coronary syndrome, previous ipsilateral transradial approach, Raynaud's syndrome, abnormal renal function with or without need for hemodialysis, known history of sensitivity to local anesthetics, non-palpable radial pulse, abnormal Barbeau's test and patient's refusal.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
EMLA anesthetic ointment (AO)Local anestheticIn AO group a layer of 2.5 gr EMLA cream (standard adult dose) is applied to both wrists, 1 cm above the styloid process of the radius 30 minutes before the puncture, by an experienced cathlab nurse.
Local Skin Anesthetic Injection (LA)local anaesthetic injectionIn LA group the radial artery is infiltrated with 1-2 mL of 2% lidocaine, using a 26 G needle, 0.5-1 cm proximal to the styloid process one minute before the puncture
Primary Outcome Measures
NameTimeMethod
Visual Analog Scale of Pain Perception during sheath insertionDuring artery puncture

The primary end-point of the study is the perception of radial pain assessed during artery puncture

Visual Analog Scale of Pain Perception after sheath removal30 minutes after sheath removal

The primary end-point of the study is the perception of radial pain assessed 30 minutes after sheath removal

Secondary Outcome Measures
NameTimeMethod
Puncture efficiency (number of puncture attempts)During radial artery catheterization

The number of puncture attempts, the total time required before successful sheath insertion are documented in each group and constitute the secondary end points of the study.

Radial artery spasmDuring radial artery catheterization

The occurrence of radial artery spasm in each group during radial artery catheterization

Trial Locations

Locations (1)

Hippocration Hospital, Athens University Medical School

🇬🇷

Athens, Attiki, Greece

© Copyright 2025. All Rights Reserved by MedPath